Gianluca Giorgi
Università degli Studi di Siena
Dipartimento di Biotecnologie, Chimica e Farmacia
via Aldo Moro 53100 Siena
e-mail: gianluca.giorgi@unisi.it Tel. 0577-234241
La Spettrometria di Massa nello Studio di Proteine e
Peptidi
La Spettrometria di Massa nello studio di Proteine e Peptidi
1. Studio
1. Studio didiProteineProteine i) Estrazione ii) Separazione
iii) Determinazione del PM
i) MALDI-TOF: spettro, risoluzione ii) ESI: ioni multicarica, risoluzione iii) Quale massa?
iv) Ricerca in banca dati
iv) Determinazione della struttura (Sequenza AA): MSn i) Proteina in toto: ECD, ETD
ii) Digestione enzimatica ÆPeptidi i) MALDI: peptide mass fingerprinting ii) HPLC-ESI-MS e MSn
iii) Ricerca in banca dati
MALDI ESI iii) Determinazione del peso molecolare
1. Studio
1. Studio didiProteineProteine i) Estrazione ii) Separazione
MALDI-TOF linear mass spectrum of intact protein: Hg-Papain oligomerization Proteine - Determinazione del PM
MALDI-TOF: spettro, risoluzione
MALDI TOF mass spectrum of a mixture of ubiquitin, cytochrome C and equine myoglobin using 2,5-dihydroxybenzoic acid (DHB) as the matrix.
Proteine - Determinazione del PM MALDI-TOF: spettro, risoluzione
R=100.000
citocromoc#1-11RT:0.01-0.23 AV:11SM:9GNL:7.40E5 F:+ p Full ms [ 600.00-2000.00]
700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900 2000
m/z 0
20 40 60 80 100
Relative Abundance
942.2 1020.4
1112.9 1529.5
1359.8 1224.0 875.1
816.9
1747.8 765.9
721.1 683.3
citocromoc#12-18 RT:10.48-10.78 AV:7SM:9GNL:1.61E4 F:+ Z ms [ 1480.00-1580.00]
1526 1528 1530 1532 1534 1536 1538 1540 1542
m/z 0
20 40 60 80 100
Relative Abundance
1530.3 1530.0
1530.7 1529.8 1530.9
1531.0 1531.2 1529.6
1534.7
1531.7 1535.1
1529.5 1534.3 1535.4 1539.5 1539.8
1529.4
Proteine - Determinazione del PM ESI: ioni multicarica, risoluzione
600 800 1000 1200 1400 1600 1800 2000 m/z
0 10 20 30 40 50 60 70 80 90 100
Relative Abundance
1748 1529
1224 1360 1113 +12
1020
875
817
766 681
646
942
+7 +8
+10 +9 +11
+14
+15
+16 +18
+19
+13
+17 766
Assegnamento delle cariche
11500 12000 12500 13000
mass
0 10 20 30 40 50 60 70 80 90 100
Relative Abundance
12231.0
12326.0
12423.0
Spettro deconvoluto
in silico
ESI (+) of Ubiquitin 1,040,000 Resolution at m/z 779
0.09u
0.09u
Spettrometria di massa ……..
Quale massa?
Proteine & Peptidi- Determinazione del PM
L’accuratezza di massa diminuisce all’aumentare della grandezza dello ione
Poiché una proteina è una molecola grande, occorre
elevatissima risoluzione e notevole accuratezza di massa (FT-ICR) per poter avere informazioni univoche sulla sua formula bruta
La Spettrometria di Massa nello studio di Proteine e Peptidi 1. Studio
1. Studio didiProteineProteine i) Estrazione ii) Separazione
iii) Determinazione del PM
i) MALDI-TOF: spettro, risoluzione ii) ESI: ioni multicarica, risoluzione iii) Quale massa?
iv) Ricerca in banca dati
iv) Determinazione della struttura
(Sequenza AA): MSn i) Proteina in toto: ECD, ETDii) Digestione enzimaticaÆPeptidi i) MALDI: peptide mass fingerprinting ii) HPLC-ESI-MS e MSn
iii) Ricerca in banca dati
i) Proteina in toto:
Determinazione della struttura: MS
nCID non riesce a frammentare ioni prodotti da molecole grandi (PM > 3000 ca)
La decomposizione di ioni prodotti da molecole grandi può avvenire solo attraverso l’interazione con
elettroni:
ECD = electron capture dissociation (FT-ICR) ETD = electron transfer dissociation (2D e 3D IT)
i) Proteina in toto:
Determinazione della struttura: MS
nECD = electron capture dissociation (FT-ICR) ETD = electron transfer dissociation (Linear IT)
Approccio Top Down
ECD, EDT
Proteina
[M+nH]
n+Frammenti
Proteina in toto
Determinazione della struttura
MS
2Enzyme
1 Protein
(in solution)
Many Peptide s
(in solution) Determinazione della struttura
ii) Digestione enzimatica Æ Peptidi
Approccio Bottom Up
Trypsin:
Lys, Arg S
S
Database
search
Identification of a Protein via Peptide Mass Fingerprinting
m/z
Intensity
MQRVNMIMAESPSLITICLLGYLLSAECT VFLDHENANKILNRPKRYNSGKLEEFVQ GNLERECMEEKCSFEEAREVFENTEK TTEFWKQYVDGDQCESNPCLNGGSCK DDINSYECWCPFGFEGKNCELDVTCNI KNGRCEQFCKNSADNKVVCSCTEGYR LAENQKSCEPAVPFPCGRVSVSQTSK LTRAEAVFPDVDYVNPTEAETILDNITQ GTQSFNDFTRVVGGEDAKPGQFPWQ VVLNGKVDAFCGGSIVNEKWIVTAAHC VETGVKITVVAGEHNIEETEHTEQKRN VIRAIIPHHNYNAAINKYNHDIALLELDE PLVLNSYVTPICIADKEYTNIFLKFGSG YVSGWGRVFHKGRSALVLQYLRVPLV DRATCLRSTKFTIYNNMFCAGFHEGG RDSCQGDSGGPHVTEVEGTSFLTGII SWGEECAMKGKYGIYTKVSRYVNWIK EKTKLT
Search Engine
Direct analysis of the
entire peptide mixture entire peptide mixture
Protein identification by peptide mapping
Database search (www.expasy.ch)
1 PYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTEN 51TEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSK 101 GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCV 151 LKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKR 201 CQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAM 251 ATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFS 301 YGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGA 351 AASESLFVSNHAY
MALDI-TOF-MS
# 16 Da ⇒ ox Met
900 1200 1500 1800 2100 2400 2700 3000 3300 0
25 50 75 100
Relative Intensity
Mass/Charge
Aldolase A
MS of a peptide mixture by MALDI-TOF
Peptide mass fingerprinting
MALDI-TOF
Identification of a spot based on peptide mapping
Protein identifications were made by peptide mass mapping (peptide mass fingerprinting) using an unspecified search program and an unspecified database.
Se proteine diverse, digerite con lo stesso enzima nelle stesse condizioni sperimentali, producono lo
stesso peptide mass fingerprint, le due proteine sono uguali
Se il TOF ha alta risoluzione, è possibile determinare la massa accurata e la formula bruta di
ciascun peptide
Proteine: Determinazione della struttura Digestione enzimatica ÆPeptidi
Database search
HPLC-ESI-MS e MS
nHPLC separation ESI-MS
peptide MW
Enzyme
HPLC-MS
Tempo di ritenzione di ciascun peptide
MS
496
990
1012
R=500 R=2000 R=15.000
986 987 988 989 990 991 992 993 994 995 996 997 998 m/z
0 10 20 30 40 50 60 70 80 90 100
Relative Abundance
990 989.5561
990.5588
991.5592
992.5601 993.5613 990
991
992 993
MS
496
990
1012
R=500 R=2000 R=15.000
495.2817
495.7830
496.2832
496.7837
497.2843
494.5 495.0 495.5 496.0 496.5 497.0 497.5 498.0 m/z
0 10 20 30 40 50 60 70 80 90 100
Relative Abundance
495.3
495.8
496.3
496.8
497.3
MS
496
990
1012
Se si dispone di un analizzatore con alta risoluzione e massa accurata
settori, ToF, Orbitrap, FT-ICR
è possibile misurare la massa accurata di ciascun peptide e quindi la formula bruta
Poiché le tecniche di ionizzazione utilizzate sono soft non si ha frammentazione in sorgente
e quindi non si hanno informazioni strutturali, ovvero non è possibile determinare la sequenza AA
Proteine: Determinazione della struttura Digestione enzimatica ÆPeptidi
HPLC-ESI-MS e MS
nHPLC separation ESI-MS
peptide MW
CID-MS
nDatabase search
x3
a1 b1 y3
c1 z3 x2
a2 b2 y2
c2 z2
a3 x1
b3 y1
c3 z1
Ioni C-terminali:
y, x, z
Ioni N-terminali:
b, a, c
CID-MS
ndi peptidi
Why b ions are very stable species?
but they have a cyclic oxazolonic structure They don’t have an acylium ion structure R-C≡O
+Spectroscopic Evidence for an Oxazolone Structure of the b
2Fragment Ion from Protonated Tri-Alanine
Oomens J et al, J. Am. Soc. Mass. Spectrom. 20, 334 (2009)
Whenever you identify a b ion look for an a ion at -28u.
This gives some assurance that your assignment is correct.
Also look for ammonia and water losses, -17 and -18u
respectively.
C:\CIADS\...\peptide-ms7\peptide99
peptide99#21-22RT:0.31-4.05AV:2NL:2.41E6 F:+ p Full ms [ 80.00-800.00]
100 150 200 250 300 350 400 450 500 550 600 650 700 750 800
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
556.3
578.4 582.2
peptide99#27-45RT:18.17-18.38AV:19NL:6.73E5 F:+ p Full ms2 556.00@24.00 [ 150.00-650.00]
200 250 300 350 400 450 500 550
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
425.1
538.1
397.2 556.1
426.1 510.1
336.2
279.2 493.1
205.1 m/z 556
·
MS2
b4
a4 Attribuire la giusta sequenza al peptide
Gly Phe Tyr Gly Leu/Ile
Residui AA:
Gly 57 Phe 147 Tyr 163 Leu/Ile 113
556-425=131
peptide99#46-79RT:43.66-44.05AV:24NL:1.54E5 F:+ p Full ms3 556.00@24.00 425.00@19.00 [ 115.00-650.00]
200 250 300 350 400 450 500 550
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
397.0
424.9
380.1 262.0
m/z 556
·
MS3
m/z 425
·
m/z 556
·
MS4
m/z 425
·
m/z 397
·
C:\CIADS\...\peptide-ms7\peptide99 21/02/2007 12.23.21
peptide99#69-79 RT:48.00-48.20 AV:10 NL:6.20E3
F:+ p Full ms4 556.00@24.00 425.00@19.00 397.00@25.00 [ 105.00-650.00]
150 200 250 300 350 400
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
380.0 323.0
278.0
397.1 261.9
234.1
352.0 283.2
238.1
a4
b3
Residui AA:
Gly 57 Phe 147 Tyr 163 Leu/Ile 113
119 a4
b4
m/z 556
·
MS5
m/z 425
·
m/z 397
· m/z 278
· peptide99#80-106 RT:57.64-57.75 AV:6NL:1.11E4
F:+ p Full ms5 556.00@24.00 425.00@19.00 397.00@25.00 278.00@22.00 [ 75.00-650.00]
100 150 200 250 300
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
221.0
278.0 233.0
249.8 261.1
MS6 ·
m/z 397
· m/z 278
·
m/z 221
· peptide99#85-106RT:62.54-62.96AV:21NL:6.61E3
F:+ p Full ms6 556.00@24.00 425.00@19.00 397.00@25.00 278.00@22.00 221.00@21.00 [ 60.00-650.00]
120 140 160 180 200 220
0 10 20 30 40 50 60 70 80 90 100
Relative Abundance
193.0
220.9
136.0
203.8 147.8
b2
a2
a1
Residui AA:
Gly 57 Phe 147 Tyr 163 Leu/Ile 113
b3
b2
278-221=57
m/z 193
·
MS7 ·
m/z 397
· m/z 278
·
m/z 221
·
peptide99#106-144RT:72.78-73.65 AV:38NL:7.87E2
F:+ p Full ms7 556.00@24.00 425.00@19.00 397.00@25.00 278.00@22.00 221.00@21.00 193.00@22.00 [ 50.00-6 ...
80 100 120 140 160 180 200
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
148.1
193.1
136.1
164.8
b1
a2
H2N NH
NH NH
NH OH
O
O
O
O
O HO
b
1b
2b
3b
4a
4a
2Tyr-Gly-Gly-Phe-Leu
a
1C:\CIADS\...\peptide-ms7\peptide99
peptide99#21-22RT:0.31-4.05AV:2NL:2.41E6 F:+ p Full ms [ 80.00-800.00]
100 150 200 250 300 350 400 450 500 550 600 650 700 750 800
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
556.3
578.4 582.2
peptide99#27-45RT:18.17-18.38AV:19NL:6.73E5 F:+ p Full ms2 556.00@24.00 [ 150.00-650.00]
200 250 300 350 400 450 500 550
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
425.1
538.1 397.2
556.1
426.1 510.1
336.2
279.2 493.1
205.1 m/z 556
·
MS2
b4
a4 Attribuire la sequenza al peptide
y3
Cyclic peptides Cyclic peptides:
Naturally occurring in bacteria, fungi and plants Synthetic compounds
They can have a lot of biological and pharmaceutical properties:
enzyme inhibitors, antifungal and antibacterial agents, immunosuppressant, antibiotics and anticancer drugs
Highly selective metal ion chelators:
carriers of metal ions inside the cells. Use in radiotherapy Better bioavailability and higher resistance to proteolytic degradation than their linear analogues
Brodbelt et al. J Am Soc Mass Spectrom 2004, 15, 1039–1054
Characterization and sequencing of cyclic peptides represent an important challenge for mass spectrometry.
The elimination of an aminoacidic residue must involve the fission of two bonds of the cycle.
No definite terminations, as it occurs in their linear analogues.
The ring-opening may occur at several backbone positions, meaning that all the fragment ions are not referenced to a single “terminal” position.
peptideDK13_elisa_070919143425#161RT:1.05AV:1NL:1.06E9 F:FTMS + p ESI Full ms [125.00-1200.00]
150 200 250 300 350 400 450 500 550
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
237.6326 R=43501
474.2574 R=30701
158.7572 R=53001
[M + H]+ [M + 2H]2+
[M + 3H]3+
Resolving power S:
Orbitrap Orbitrap:
at constant detection time:
resolving power inversely proportional to √ m/z
Thus if
R=100,000 at m/z 100,
at m/z 1000 it will be R=100,000(100/1000)
1/2=31,646
RDB=double bond/ring equivalents
For ions with odd charge:
Odd-electron ions = RDB integer Even-electron ions= RDB x.5
12C 0÷30
13C 0÷1
14N 0÷10
16O 0÷15
1H 0÷60
peptideDK13_elisa_070919143425#172 231RT:1.13 1.60AV:60NL:1.09E9 F:FTMS + p ESI Full ms [125.00-1200.00]
235 236 237 238 239 240 241
m/z 0
5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
Relative Abundance
237.6325
238.1335
238.6358 239.1395
[M + 2H] 2+
peptideDK13_elisa_070919143425#172 231RT:1.13 1.60AV:60NL:1.09E9 F:FTMS + p ESI Full ms [125.00-1200.00]
235 236 237 238 239 240 241
m/z 0
5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
Relative Abundance
237.6325
238.1335
238.6358 239.1395
peptideDK13_elisa_070919143425#161RT:1.05AV:1NL:8.24E7 F:FTMS + p ESI Full ms [125.00-1200.00]
158.6 158.8 159.0 159.2 159.4 159.6 159.8
m/z 0
10 20 30 40 50 60 70 80 90 100
Relative Abundance
158.7572 R=53001
159.0917 R=53504
159.4287 R=22804
[M + 3H] 3+
—H2O
[M+H]+
—NH3 [MH—(NH3—CH2O)]+ (0.07)-Lys
-Lys (0.49)
337.1986(0.43)
-His -His peptideDK13_elisa_070919143425#538 591RT:4.41 7.95AV:54NL:3.03E7 F:FTMS + p ESI Full ms2 474.00@cid20.00 [130.00-600.00]
150 200 250 300 350 400 450
m/z 0
5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
Relative Abundance
346.1625 328.1520
474.2571 456.2468
209.1035
266.1615 237.0985
302.1615
439.2203
180.0769 365.1935 427.2204
-Lys -His
-β-Ala
—H2O
318.1677
—NH3
Residui AA:
Lys 128 His 137 Ala/β-Ala 71
Peptide solo2#1 16RT:0.02 0.27AV:16NL:2.10E5
F:+ p Full ms3 474.00@cid28.00 346.00@cid22.00 [95.00-1000.00]
100 120 140 160 180 200 220 240 260 280 300 320 340 360 m/z
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
Relative Abundance
328.2
346.1
237.0 209.1
318.1
[MH-Lys]+
—H2O
-His
CID-MS
3[MH-Lys]
+Residui AA:
Lys 128 His 137 Ala/β-Ala 71
c-(Lys- D/L -His-β-Ala-His)
NH N
NH N O
O
O O
NH2
NH HN NH
NH
N NH
NH N O
O
O O
NH2
NH HN NH
NH H+
HN NH2
O
H2N
HN N
HN
O N
NH N
O
O
m/z 346
+H+
H2N
O
N NH
N
O
m/z 209
+ H+
HN
NH N O
b3+ K/H
-
b3+ K/H m/z 346
N NH
NH N O
O
O O
NH2
NH HN NH
NH
HN
NH N O
NH2
HN
HN N N O
O O H2N
+H+
+H+
y3+K/H m/z 337
H2N
O
N NH
N
O + H+
H2N NH
O
-
m/z 209 -
80 100 120 140 160 180 200 220m/z240 260 280 300 320 340 360 380 0
20 40 60 80
100 129.1
328.1 229.1
346.1
220.3 209.1
237.7 337.1
110.1
84.1 318.1
266.2 180.1
173.7 193.2 248.1 365.1
159.7
—LysH+
[M+2H]2+
[M—H2O+2H]2+
LysH+
—LysH+
[M—NH3—H2O+2H]2+
—HisβAlaH HisβAlaH+
—HisH+
CID-MS
2[M+2H]
2+150 200 250 300 350 400 450 500 m/z
0 10 20 30 40 50 60 70 80 90 100
IntensitàRelativa (%)
246.3
335.3 281.3
472.3 454.3
383.3 207.2
264.3
401.3
150 200 250 300 350 400 450 500
m/z 0
10 20 30 40 50 60 70
150 200 250 300 350 400 450 500
m/z 0
10 20 30 40 50 60 70 80 90 100
IntensitàRelativa (%)
246.3
335.3 281.3
472.3 454.3
383.3 207.2
264.3
401.3
-His - His
- His - β-Ala
- β-Ala - β-Ala
—H2O
- Lys
CID-MS
2[M-H]
–-His
If you are working with a
tryptic peptide
, look for the arginine or lysine y1ion at the low end of the spectrum:[M+H]+-156 - 18 = penultimate b ion Arg is the carboxy AA [M+H] +-128 -18 = penultimate b ion Lys is the carboxy AA This may give you a clue to the C-terminal residue of your tryptic peptide.
In general: protonated peptide - AA residue mass - 18 = penultimate b ion or you could use the standard formula for calculating the corresponding b ion once the y ion is known.
[M+H] +- y1+1 = penultimate b ion If you are using an ion trap you may not be able to observe the low end of the spectrum, and in this case, you will need to do both of these calculations
[M+H]+ - observed b ion + 1 = corresponding y ion.
Digerito triptico [M+H]+ = 1379 (14 AA) MS/MS m/z 1379 (ion trap)
Digerito triptico [M+H]+ = 1182 (10 AA) MS/MS m/z 1182 (ion trap)
ETD, ECD
High Collision CID
Ions c, z
x3
a1 b1 y3
c1 z3 x2
a2 b2
y2
c2
z2
a3
x1
b3 y1
c3
z1
74
Loss of One Phosphorylation Loss of Two Phosphorylations
75
Single Scan Ion Trap CID with ICR Cell Detection Single Scan Ion Trap CID with ICR Cell Detection
B2+ B3+
B102+
B6+ B82+
B7+ B8+
Y9+ B9+ B5+
200 400 600 800 1000 1200 1400
m/z 0
10 20 30 40 50 60 70 80 90 100
B10+ 607.3675
600.3380
382.2561 1094.5815
254.1611
1077.5550 882.4948
674.3710
1029.5631 735.4263
1199.6681 515.2853
1086.5840
Relative Abundance
R P K P Q Q F F G L M
Ion Theoretical Measured ppm
B2+ 254.1612 254.1611 0.19
B3+ 382.2561 382.2561 -0.04 B82+ 515.2851 515.2853 0.64 B102+ 600.3378 600.3380 -0.06 B5+ 607.3675 607.3675 0.00 [M+2H]2+ 674.3713 674.3710 -0.44 B6+ 735.4260 735.4263 -0.31 B7+ 882.4944 882.4948 -0.00 B8+ 1029.5629 1029.5631 0.52 Y*9+ 1077.5550 1077.5550 -0.18
B9+ 1086.5843 1086.5840 -0.28
Y9+ 1094.5815 1094.5815 0.32 B10+ 1199.6684 1199.6681 1.17 Fragments identified with a average error of 0.03 ppm
[M+2H]2+
76
Single Scan IRMPD with ICR Cell Detection Single Scan IRMPD with ICR Cell Detection
200 400 600 800 1000 1200 1400
m/z 0
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
Relative Abundance
674.3708
254.1612
400.7012
1094.5833 600.3383
1194.9060 946.5157
515.2853 382.2563
882.4956 735.4267
1029.5646 B2+
B3+
B102+
B6+
B82+ B7+
B8+ Y9+ R P K P Q Q F F G L M
Ion Theoretical Measured ppm
B2+ 254.1612 254.1612 0.04
B3+ 382.2561 382.2563 0.38
B82 515.2851 515.2853 0.51
B102+ 600.3378 600.3383 0.69
B5+ 607.3675 607.3679 0.68 [M-NH3]2+ 665.8581 665.8581 -0.05 M2+ 674.3713 674.3708 -0.87 B6+ 735.4260 735.4267 0.85
B7+ 882.4944 882.4956 -1.30
B8+ 1029.5629 1029.5646 1.73
Y*9+ 1077.5550 1077.5547 -0.35 Y9+ 1094.5815 1094.5833 0.95 Fragments identified with a average error of 0.58 ppm [M+2H]2+
77
Single Scan ECD with ICR Cell Detection Single Scan ECD with ICR Cell Detection
R P K P Q Q F F G L M
Fragments identified with a average error of 0.56 ppm
200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400
m/z 0
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
Relative Abundance
674.3715
624.3944
899.5217 752.4530
496.3355 1216.6959
1046.5898
1348.7418 1331.7167
C4+ C6+
C7+
C8+ C5+
C10+
[M+2H]+ [M+2H]2+
1078.5626 Z9+
1103.6123 C9+
[M-NH3]+
Ion Theoretical Measured ppm
C4+ 496.3354 496.3355 0.20
C5+ 624.3940 624.3944 0.64
[M+2H]2+ 674.3713 674.3715 0.29
C6+ 752.4526 752.4530 0.53
C7+ 899.5210 899.5217 0.78
C8+ 1046.5894 1046.5898 0.38
Z9+ 1078.5628 1078.5634 0.55
C9+ 1103.6109 1103.6112 0.27
C10+ 1216.6949 1216.6959 0.82
[M-NH3]2+ 1331.7158 1331.7167 0.67 [M+2H]+ 1348.7432 1348.7418 -1.00
Top down
vs
Bottom up
approaches
for studying large molecules
i) Proteina in toto:
Determinazione della struttura: MS
nECD = electron capture dissociation (FT-ICR) ETD = electron transfer dissociation (Linear IT)
Approccio Top Down
x3
a1 b1 y3
c1 z3 x2
a2 b2 y2
c2 z2
a3 x1
b3 y1
c3 z1
Top
down
ETD
Electron Transfer Dissociation
Loss of One Phosphorylation Loss of Two Phosphorylations
Courtesy by G. Vago Thermo